Cerebrovascular Dynamics in Moyamoya Disease

Moyamoya disease is a progressive cerebrovascular disorder characterised by stenosis or occlusion of the distal internal carotid arteries and their major branches, accompanied by the development of fragile collateral vessels that resemble a “puff of smoke” on angiography. The dynamic interplay between arterial narrowing, collateral formation and haemodynamic stress underlies both ischaemic and haemorrhagic events in affected individuals. At the molecular level, variants of the RNF213 gene have emerged as the principal susceptibility factor, influencing endothelial proliferation, inflammatory responses and extracellular matrix remodelling. Altered shear stress and impaired angiogenic capacity contribute to vessel wall instability, while high-resolution imaging has revealed patterns of concentric or eccentric wall enhancement that correlate with acute infarction risk. Advances in metabolic profiling and machine-learning algorithms are refining non-invasive diagnostic approaches, whereas evolving surgical and endovascular techniques aim to restore adequate perfusion. A deeper understanding of the genetic, cellular and biophysical determinants of collateral circulation, vascular remodelling and cerebral blood flow regulation promises to inform targeted therapies and improve outcomes for this global cause of childhood and adult stroke.

Research from Nature Portfolio

Functional studies have dissected the role of RNF213 in endothelial cells, demonstrating that pro-inflammatory cytokines activate RNF213 transcription via AKT and PKR pathways, and that its knockdown impairs cell cycle progression and angiogenic potential, implicating RNF213 as a nodal regulator of inflammation-driven vascular remodelling. Structural analysis of RNF213 revealed twin AAA+ ATPase modules forming a ring-shaped oligomer that undergoes nucleotide-dependent conformational shifts, suggesting a mechanical basis for its involvement in vessel formation. High-resolution MRI investigations have shown that higher-grade vessel wall enhancement correlates strongly with acute ischaemic infarction in Moyamoya vasculopathy, indicating that contrast uptake patterns can serve as biomarkers of vessel instability and stroke risk.

Cerebrovascular Dynamics in Moyamoya Disease publication trend

The graph below shows the total number of articles in cerebrovascular dynamics in moyamoya disease across all publications each year (not limited to Nature Index journals).

Technical terms

Collateral circulation: network of small vessels that develops to bypass an occluded artery and maintain tissue perfusion.

RNF213: a susceptibility gene encoding a large AAA+ ATPase and E3 ubiquitin ligase crucial to endothelial response and vessel development.

Angiogenesis: the process by which new blood vessels form from pre-existing ones, essential in collateral vessel growth.

Vessel wall enhancement: increased contrast uptake in the arterial wall on high-resolution MRI, reflecting inflammation or endothelial disruption.

Serum metabolic fingerprint: the profile of small-molecule metabolites in blood that can serve as a diagnostic signature for disease.

Perfusion imaging: techniques such as CT or MRI perfusion that measure blood flow and volume within brain tissue.

References

1. Non‐Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning. Advanced Science (2024).
2. Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions. MedComm (2025).
3. Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development. PLOS ONE (2011).
4. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Scientific Reports (2015).
5. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Scientific Reports (2014).
6. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. eLife (2020).
7. The Contrast Enhancement of Intracranial Arterial Wall on High-resolution MRI and Its Clinical Relevance in Patients with Moyamoya Vasculopathy. Scientific Reports (2017).